You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 6, June 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Incidence of Hypercalcemia and Malignant Neoplasm

Michael E. Burt, MD; Murray F. Brennan, MD

Arch Surg. 1980;115(6):704-707.


Abstract

• Hypercalcemia often complicates the course of patients with malignant neoplasms. Since this metabolic derangement is potentially lethal, knowledge of the expected relative incidence of hypercalcemia in various malignant neoplasms is of importance. The incidence of hypercalcemia and malignant neoplasm at the Clinical Center, National Institutes of Health, Bethesda, Md, was reviewed. Of 17,706 admissions (multiple admissions counted once), the overall incidence of hypercalcemia for all disorders was 5.0%; of these, 38.0% (338 patients) had associated neoplasms (99.4% malignant). Primary hyperparathyroidism represented 19.6% of those admitted with hypercalcemia, and nonneoplastic disorders represented 10.7%. Of the 338 patients with hypercalcemia associated with neoplasia, 44.1% had hematologic and 41.4% had solid neoplasms. The relative incidences of hypercalcemia and neoplasia are reported for each of the solid and hematologic neoplasias evaluated.

(Arch Surg 115:704-707, 1980)



Author Affiliations

From the Surgery Branch, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Md.


Footnotes

Accepted for publication Jan 17, 1980.

Reprint requests to Surgery Branch, NCI, Bldg 10, Rm 10N111, Bethesda, MD 20205 (Dr Brennan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Cancer-Associated Hypercalcemia: Double-blind Comparison of Rapid and Slow Intravenous Infusion Regimens of Pamidronate Disodium and Saline Alone
Gucalp et al.
Arch Intern Med 1994;154:1935-1944.
ABSTRACT  

Hypercalcemia: A Complication of Advanced Chronic Liver Disease
Gerhardt et al.
Arch Intern Med 1987;147:274-277.
ABSTRACT  

Humoral Hypercalcemia in Hodgkin's Disease: Association With Elevated 1,25-Dihydroxycholecalciferol Levels and Subperiosteal Bone Resorption
Zaloga et al.
Arch Intern Med 1985;145:155-157.
ABSTRACT  

Hypercalcemia and Primary Hepatic Tumors
Oldenburg et al.
Arch Surg 1982;117:1363-1366.
ABSTRACT  

Hypercalcemia in Patients With Breast Cancer: Osseous Metastases, Hyperplastic Parathyroid Tissue, or Pseudohyperparathyroidism?
Hickey et al.
Arch Surg 1981;116:545-552.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.